ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    Complement Binding Activity (C3d, C1q) of De Novo Donor-Specific HLA Antibody Is Associated with Increased Risk of Antibody-Mediated Rejection in Non-Sensitized Kidney Transplant Recipients.

    H. Lee,1 E. Han,1 A.-R. Choi,1 K. Park,2 J. Ryu,2 B. Chung,3 C. Yang,3 E.-J. Oh.1

    1Laboratory Medicine, The Catholic University of Korea, Seoul, South Korea (KOR), Korea; 2Biomedical Science, Graduate School, The Catholic University of Korea, Seoul, South Korea (KOR), Korea; 3Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea (KOR), Korea

    Despite advances in therapeutic strategies and medicine, antibody mediated rejection (AMR) is a leading cause of kidney graft loss. The complement binding activity of donor-specific…
  • 2017 American Transplant Congress

    Dual Treatment of Suboptimal Doses of CsA and MSC Infusion Fully Prevents Acute Rejection in an Allogenic Model of Renal Transplantation.

    L. de Ramon,1 A. Merino,1 E. Ripoll,1 N. Bolaños,1 M. Gomà,3 J. Cruzado,1,2 J. Grinyó,1,2 J. Torras.1,2

    1Experimental Nephrology, IDIBELL-UB, Hospitalet Llobregat, Barcelona, Spain; 2Nephrology, Hospital Universitari de Bellvitge, Hospitalet Llobregat, Barcelona, Spain; 3Pathology, Hospital Universitari de Bellvitge, Hopitalet Llobregat, Barcelona, Spain

    The immunomodulatory characteristics of mesenchymal stem cells (MSCs) may lead to multifaceted strategies in rejection of organ transplantation. This study was designed to investigate the…
  • 2017 American Transplant Congress

    Is Thymic Function Determining Rejection Onset in Heart Transplantation?

    A. Sannier,1,2 R. Dorent,1,3 M. Le Borgne,1 N. Stroumza,1 J. Senemaud,1 L. Louedec,1 F. Andreata,1 A. Gaston,1 C. Deschildre,1 P. Nataf,1,3 A. Couvelard,2 G. Caligiuri,1 A. Nicoletti.1

    1Inserm U1148, Diderot University, Paris, France; 2Pathology Department, Bichat Hospital, Paris, France; 3Cardiac Surgery Department, Bichat Hospital, Paris, France

    The thymus is the primary site of T cell development, involuting into fatty tissue in adults. Thymic function persists in the adulthood and may be…
  • 2017 American Transplant Congress

    Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection.

    G. Piñeiro,1 E. Desousa,1 J. Villarreal,1 M. Lozano,2 J. Cid,2 M. Sole,3 F. Oppenheimer,1 F. Diekmann.1

    1Nephrology and Renal Transplant, Hospital Clinic de Barcelona, Barcelona, Spain; 2Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic de Barcelona, Barcelona, Spain; 3Pathology, Hospital Clinic de Barcelona, Barcelona, Spain

    Acute antibody mediated rejection (AMR) is a major cause of allograft loss.We retrospectively reviewed all kidney allograft recipients between 2002 and March 2016. Investigated the…
  • 2017 American Transplant Congress

    De Novo Malignancy Occurrence After Kidney Transplantation in HLA-Sensitized Patients Treated with B-Cell Targeting Therapy.

    L. Couzi,1,2,3 P. Davis,1 J. Visentin,1,2,3 B. Taton,1 G. Guidicelli,1 H. Kaminski,1,2,3 P. Merville,1,2,3 T. Bachelet.4

    1CHU de Bordeaux, Bordeaux, France; 2Université de Bordeaux, Bordeaux, France; 3UMR CNRS 5164 Immunoconcept, Bordeaux, France; 4Clinique Saint-Augustin-CTMR, Bordeaux, France

    Management of high risk transplantations in patients with preformed DSA still remains a dilemma. Many groups propose to increase the immunosuppression in these patients by…
  • 2017 American Transplant Congress

    Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.

    M. Gallo, J. Trivedi, D. Abramov, R. Vijayakrishnan, M. Slaughter.

    University of Louisville, Louisville

    Background. This study evaluated the management of immunosuppressive therapy and the incidence of acute heart rejection within 1 year from concomitant heart-kidney transplantation (cHTKx) compared…
  • 2017 American Transplant Congress

    Which Tr1 Is Better for Transplant Tolerance Induction: Comparing the Tr1 Generated by IL-27 or TGF-βplus IL-27.

    G. Gu, H. Hang, Q. Xia.

    Department of Hepatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

    IL-10 producing T cells (Tr1) are important for the transplant tolerance induction. However, Tr1 can be induced in two methods: IL-27 or TGF-βplus IL-27. We…
  • 2017 American Transplant Congress

    Steroid Free Maintenance Immunosupression in Kidney Transplantation: Indiana University Experience.

    S. Hussain, T. Taber, A. Sharfuddin, M. Yaqub, W. Goggins, D. Mishler, O. Adebiyi.

    Renal Transplant, Indiana University School of Medicine, Indianapolis, IN

    Background: Steroid based maintenance Immunosuppression (IS) regimen is the standard protocol for many kidney transplant(tx) centers. However, concerns for chronic steroid impact on patients remains…
  • 2017 American Transplant Congress

    Effect of Hepatitis C (HCV) Treatment on Rejection Incidence and Severity in Post-Liver Transplant Patients.

    C. Skillin, M. Mba, B. Madani, C. Frenette.

    Organ Transplant, Scripps Clinic, La Jolla, CA

    Introduction: Hepatitis C remains an important source of morbidity and mortality post liver transplant. Little is known about the long term effects of direct acting…
  • 2017 American Transplant Congress

    Clinical Significance of Alloantibodies in Hand Transplantation: Impact on Rejection and Functional Outcome.

    E. Berglund,1 M. Andersen Ljungdahl,1 D. Bogdanovic,1 D. Berglund,3 J. Wadström,1 A. Weissenbacher,2 P. Petruzzo,4 S. Schneeberger.2

    1Karolinsk Institutet, Dpt of Clinical Science, Intervention, and Technology, Stockholm, Sweden; 2Innsbruck Medical University, Center for Operative Medicine, Innsbruck, Austria; 3Uppsala University, Dpt of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala, Sweden; 4Edouard Herriot Hospital, Dpt of Transplantation, Lyon, France

    Purpose: Although alloantibodies, and donor-specific antibodies (DSA) in particular, are well-known to negatively impact graft survival in human solid organ transplantation, little is known about…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences